Singapore Market Roundup (10-Sep-2026): RHB views Raffles Medical's 52-week low as a buy signal.
RHB views Raffles Medical's 52-week low as a buying chance. Citi gives a 'buy/high risk' rating to CSE Global, while Maybank's Seet is bullish on...
114 Views
Singapore Market Roundup (09-Sep-2026): Maybank's Seet lowers Frencken target price after $100M
Maybank's Seet remains positive on Frencken despite lowering the target price after a $100M placement. UOBKH cuts Delfi's target price amid cocoa...
115 Views
Primer: Frencken (FRKN SP) - Jan 2026
Short-Term Headwinds vs. Long-Term Growth: Frencken faces near-term revenue challenges, particularly from a key European semiconductor client...
191 Views
Singapore Market Roundup (14-Aug-2026): RHB and DBS keep 'neutral' stance on Wilmar after strong
RHB and DBS keep a 'neutral' outlook on Wilmar despite strong 2QFY2026 results, while analysts are optimistic about Frencken and Singtel's earnings.
109 Views
Stake Additions by Q&M Dental, Frencken, Zhongmin Baihui Retail, and Accrelist directors
Institutions were net sellers of Singapore stocks from Nov 28 to Dec 4, with a net outflow of S$78 million. Singtel led share buybacks with...
246 Views